Medical expenditures of children in the United States with fetal alcohol syndrome

Neurotoxicology and Teratology

Volumn 33, Issue 2, 2011, Pages 322-324

  Amendah, Djesika D ^a   Grosse, Scott D ^a   Bertrand, Jacquelyn ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Cost; Expenditures; Fetal alcohol syndrome; Intellectual disability; Medicaid

Indexed keywords

ARTICLE; CHILD; CHILD HEALTH CARE; CONTROLLED STUDY; DATA BASE; FETAL ALCOHOL SYNDROME; HEALTH CARE COST; HUMAN; INTELLECTUAL IMPAIRMENT; INTERNATIONAL CLASSIFICATION OF DISEASES; MEDICAID; PRENATAL EXPOSURE; PRIORITY JOURNAL; UNITED STATES;

CHILD; DATABASES, FACTUAL; FEMALE; FETAL ALCOHOL SYNDROME; HEALTH EXPENDITURES; HUMANS; MEDICAID; MENTAL RETARDATION; PREGNANCY; UNITED STATES;

EID: 79953307648     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ntt.2010.10.008     Document Type: Article

References (10)

1. Amendah D, Grosse SD, Peacock G, Mandell D. Economic costs of austism spectrum disorders: a review, in: Amaral GD, Dawson G, Geschwind DH (Ed.), Austism Spectrum Disorders, Oxford University Press, New York, in press.
2. Bureau of Labor Statistics, Consumer Price Index, United States Department of Labor Available at:, accessed on 6/23/10. http://www.bls.gov/cpi/.
3. Druschel C.M., Fox D.J. Issues in estimating the prevalence of fetal alcohol syndrome: examination of 2 counties in New York State. Pediatrics 2007, 119:e384-e390.
4. Hymbaugh K., Miller L.A., Druschel C.M., Podvin D.W., Meaney F.J., Boyle C.A. A multiple source methodology for the surveillance of fetal alcohol syndrome-The Fetal Alcohol Syndrome Surveillance Network (FASSNet). Teratology 2002, 66(Suppl 1):S41-S49.
5. Klug M.G., Burd L. Fetal alcohol syndrome prevention: annual and cumulative cost savings. Neurotoxicol Teratol 2003, 25:763-765.
6. May P.A., Gossage J.P., Wendy O.K., Luther K.R., David B., Melanie M., et al. Prevalence and epidemiologic characteristics of FASD from various research methods with an emphasis on recent in-school studies. Dev Disabil Res Rev 2009, 15:176-192.
7. Mvundura M., Amendah D., Sprinz P.G., Kavanagh P.L., Grosse S.G. Medical care utilization and expenditures in privately and publicly insured children with sickle cell disease in the United States. Pediatr Blood Cancer 2009, 53:642-646.
8. Organisation for Economic Co-operation and Development (OECD) Purchasing Power Parities (PPPs) for OECD Countries since 1980 in: OECD (Ed.), OECD statistics on Purchasing Power Parities (PPP), OECD, Paris, 2008. Available at oecdoecd accessed on 6/23/10. http://www.oecd.org/dataoecd/61/56/39653523.xls.
9. Stade B., Ungar W.J., Stevens B., Beyene J., Koren G. The burden of prenatal exposure to alcohol: measurement of cost. J FAS Int 2006, 4:e5.
10. Yeargin-Allsopp M., Boyle C. Overview: the epidemiology of neurodevelopmental disorders. Ment Retard Dev Disabil Res Rev 2002, 8:113-116.